BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

7/25/2022

FDA Issues 5-Year Debarment Order Against Kenneth Zipperer for Mail Fraud

The Food and Drug Administration (FDA) has issued a final debarment order against Kenneth Zipperer, barring him from importing or offering for import any drug into the United States for 5 years, following his conviction for mail fraud related to the importation of a controlled substance.

7/25/2022

FDA Releases Final Guidance on Unique Device Identification Policy for Class I and Unclassified Devices

The Food and Drug Administration (FDA) has announced the availability of a final guidance document that updates its policy on compliance dates for Class I and unclassified devices, direct marking, and Global Unique Device Identification Database requirements. The guidance aims to clarify FDA's policy for certain Class I devices and extend the existing compliance policy for an additional 75 days.

7/25/2022

FBI Submits Information Collection Request to OMB for Review and Clearance

The FBI's Violent Criminal Apprehension Program and Critical Incident Response Group have submitted a request to the Office of Management and Budget for review and clearance of a proposed eCollection of eComments, as part of a revision to a previously approved information collection, in accordance with the Paperwork Reduction Act of 1995.

7/25/2022

DOL Submits OSHA-Sponsored ICR for Review and Approval

The Department of Labor is seeking public comments on an Occupational Safety & Health Administration-sponsored information collection request for review and approval under the Paperwork Reduction Act of 1995.

7/25/2022

Federal Agencies Extend Market Risk Regulatory Report Collection Without Revision

The Office of the Comptroller of the Currency (OCC), the Federal Reserve Board (Board), and the Federal Deposit Insurance Corporation (FDIC) are extending the Market Risk Regulatory Report for Institutions Subject to the Market Risk Capital Rule without revision for three years, following a 60-day public comment period that ended on May 27, 2022, and no comments received.